Literature DB >> 11049852

Endothelin and ET(A) receptors in long-term arterial pressure homeostasis in conscious nonhuman primates.

G A Reinhart1, L C Preusser, T J Opgenorth, C D Wegner, B F Cox.   

Abstract

This study was designed to quantify the long-term contribution of endogenous endothelin-1 (ET-1) and ET(A) receptors to the regulation of arterial pressure under normal conditions in nonhuman primates. Therefore, mean arterial pressure (MAP) and heart rate were measured 24 h/day with the use of telemetry techniques in conscious cynomolgus monkeys under control conditions, during administration of an ET(A) selective receptor antagonist (ABT-627; 5 mg/kg, 2 times a day by mouth, 4 days), and a 6-day posttreatment period. Systemic ET(A) blockade reduced MAP (24 h) from 89 +/- 3 to 82 +/- 2 and 79 +/- 2 mmHg on days 1 and 4, respectively. Subsequently, MAP remained suppressed for 3 days posttreatment. Heart rate increased from 111 +/- 5 to 122 +/- 4 and 128 +/- 6 beats/min on days 1 and 4 of ABT-627, respectively, and remained above control for 3 days posttreatment. Plasma ET-1 concentration increased from 1.0 +/- 0.3 to 1.9 +/- 0.4 pg/ml in response to ABT-627 (day 4) but decreased to control values 4 days posttreatment. These data demonstrate a physiologically important role for endogenous ET-1 and ET(A) receptors in the long-term regulation of arterial pressure and plasma ET-1 levels in the conscious nonhuman primate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049852     DOI: 10.1152/ajpregu.2000.279.5.R1701

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  2 in total

1.  An activated renin-angiotensin system maintains normal blood pressure in aryl hydrocarbon receptor heterozygous mice but not in null mice.

Authors:  Nan Zhang; Larry N Agbor; Jason A Scott; Tyler Zalobowski; Khalid M Elased; Alicia Trujillo; Melissa Skelton Duke; Valerie Wolf; Mary T Walsh; Jerry L Born; Linda A Felton; Jian Wang; Wei Wang; Nancy L Kanagy; Mary K Walker
Journal:  Biochem Pharmacol       Date:  2010-03-30       Impact factor: 5.858

2.  Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects.

Authors:  Jasper Dingemanse; Martine Clozel; Paul L M van Giersbergen
Journal:  Br J Clin Pharmacol       Date:  2002-04       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.